Table 2.
Clinical efficacy (n = 54).
| Group | CR | PR | SD | PD | DCR |
|---|---|---|---|---|---|
| COG | 12 (22.22) | 19 (35.19) | 13 (24.07) | 10 (18.52) | 44 (81.48) |
| STG | 21 (38.89) | 25 (46.30) | 5 (9.26) | 3 (5.56) | 51 (94.44) |
| χ 2 | 4.285 | ||||
| P | 0.038 |
Clinical efficacy (n = 54).
| Group | CR | PR | SD | PD | DCR |
|---|---|---|---|---|---|
| COG | 12 (22.22) | 19 (35.19) | 13 (24.07) | 10 (18.52) | 44 (81.48) |
| STG | 21 (38.89) | 25 (46.30) | 5 (9.26) | 3 (5.56) | 51 (94.44) |
| χ 2 | 4.285 | ||||
| P | 0.038 |